Clinical trials
Recruiting Fallopian Tube Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
94 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 8 |
| 2021 | 5 |
| 2022 | 14 |
| 2023 | 11 |
| 2024 | 16 |
| 2025 | 23 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 94 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 5 |
| AstraZeneca | 4 |
| Regeneron Pharmaceuticals | 4 |
| AbbVie | 3 |
| Merck Sharp & Dohme LLC | 3 |
| Roswell Park Cancer Institute | 3 |
| Shanghai Gynecologic Oncology Group | 3 |
| Beijing Biotech | 2 |
| Genmab | 2 |
| Imunon | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fallopian Tube Neoplasms | 94 |
| Ovarian Neoplasms | 72 |
| Carcinoma, Ovarian Epithelial | 23 |
| Endometrial Neoplasms | 22 |
| Breast Neoplasms | 10 |
| Uterine Cervical Neoplasms | 10 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Carcinoma, Renal Cell | 5 |
| Neoplasms | 5 |
| Peritoneal Neoplasms | 5 |
Trials
Showing 26 to 50 of 94. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.